Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 268-820-3 | CAS number: 68140-98-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
The Bacterial Reverse Mutation Assay (according to OECD Guidelines for Testing of Chemicals No.: 471) with 4-ethyl-2-(8-heptadecenyl)-2-oxazoline-4-methanol showed, that the test item did not induce gene mutations by frameshift or base-pair substitution in the genome of the tester strains used. Therefore, 4-ethyl-2-(8-heptadecenyl)-2-oxazoline-4-methanol is considered non-mutagenic in this bacterial reverse mutation assay.
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Species / strain / cell type:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 Mix
- Test concentrations with justification for top dose:
- Initial Mutation Test: 1600/ 500/ 160/ 50/ 16/ 5/ 1.6/ 0.5 µg/plate
Confirmatory Mutation Test and Complementary Plate Incorporation Test: 5000/ 1600/ 500/ 160/ 50/ 16/ 5/ 1.6/ 0.5/ 0.16 µg/plate
- Due to the strong inhibition observed in the Initial Mutation Test in the case of Salmonella typhimurium TA1537 in the absence of exogenous metabolic activation (-S9 Mix); the examined concentration range was modified in the subsequent Confirmatory Mutation Test and the following concentration levels were investigated at this experimental part (S. typhimurium TA1537):
-S9 Mix: 50, 16, 5, 1.6, 0.5 and 0.16 μg/plate;
+S9 Mix: 1600; 500; 160; 50; 16 and 5 μg/plate.
- Inhibition was not noticed in the Initial Mutation Test in the case of Escherichia coli WP2 uvrA in the examined concentration range; therefore in the Confirmatory Mutation Test in the case of Escherichia coli WP2 uvrA the following concentration levels were investigated in the absence of and presence of exogenous metabolic activation (±S9 Mix):
±S9 Mix: 5000, 1600, 500, 160, 50 and 16 μg/plate.
- In the Complementary Plate Incorporation Test the Escherichia coli WP2 uvrA was investigated with the following concentration levels:±S9 Mix: 5000, 1600, 500, 160 and 50 μg/plate.
- The examined concentration levels were not modified in the case of S. typhimurium TA98, TA100 and TA1535 strains. - Vehicle / solvent:
- - vehicle for the test item: dimethyl sulfoxide (DMSO)
- vehicle for positive and negative (vehicle) controls: DMSO, Ultrapure water (prepared in the testing laboratory) - Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- sodium azide
- methylmethanesulfonate
- other: 4-nitro-1,2-phenylene-diamine; 2-aminoanthracene
- Details on test system and experimental conditions:
- METHOD OF APPLICATION
plate incorporation in experiment 1 (initial mutation test + complementary plate incorporation test), pre-incubation method in experiment 2 (confirmatory mutation test)
Each assay was conducted with and without metabolic activation (±S9 Mix). In parallel with the Confirmatory Mutation Test, the plate incorporation test was completed (Complementary Plate Incorporation Test) with investigation of additional concentration levels in the case of Escherichia coli WP2 uvrA, because of the lacking inhibition in the already examined concentration range. The concentrations, including the controls, were tested in triplicate (positive and negative controls were run concurrently).
CONCENTRATION RANGE FINDING and CYTOTOXICITY DETERMINATION
The toxicity of the test item was determined with strains Salmonella typhimurium TA98 and TA100 in a pre-experiment. 7 concentrations were tested for toxicity and mutation induction with 3 plates each. The experimental conditions in this pre-experiment were the same as for the main experiment I (plate incorporation test) and included non-activated and S9 activated test conditions with appropriate positive and negative controls. The test item concentrations, including the controls (untreated, vehicle and positive reference) were tested in triplicate. In the toxicity test the concentrations examined were: 5000, 1600, 500, 160, 50, 16 and 5 μg/plate.
EXPERIMENTAL PERFORMANCE
The standard plate incorporation procedure was performed as an initial mutation test and Complementary Plate Incorporation Test. Bacteria (cultured in Nutrient broth No. 2.) were exposed to the test item, both in the presence and absence of an appropriate metabolic activation system.
Molten top agar was prepared and kept at 45 °C. 2 mL of top agar was aliquoted into individual test tubes (3 tubes per controls or concentration levels). The equivalent number of minimal glucose agar plates was properly labelled. The test item and other components were prepared fresh and added to the overlay (45 °C).
The content of the tubes:
Top agar 2000 μL
Vehicle or solution of test item or reference controls 100 μL
Over-night culture of test strain 100 μL
Phosphate buffer (pH: 7.4) or S9 Mix 500 μL
This solution was mixed and poured on the surface of minimal agar plates. For activation studies, instead of phosphate buffer, 0.5 mL of the S9 Mix were added to each overlay tube. The entire test consisted of non-activated and activated test conditions (without S9 Mix and with addition of S9 Mix) and each of them with the addition of negative and positive controls.
For the pre-incubation method, before overlaying the test item, the bacterial culture and the S9 Mix or phosphate buffer was added into the appropriate tubes, providing direct contact between bacteria and the test item (in its solvent). These tubes were gently mixed and incubated for 20 min at 37 ºC using a shaker. After the incubation the content of the tubes was added to the molten top agar prior to pouring onto the surface of minimal agar plates.
After solidification the plates were inverted and incubated at 37 °C for approximately 48 hours in the dark. - Evaluation criteria:
- A test item is considered mutagenic if:
- a dose-related increase in the number of revertants occurs and/or;
- a reproducible biologically relevant positive response for at least one of the dose groups occurs in at least one strain with or without metabolic activation.
An increase is considered biologically relevant if:
- in strain Salmonella typhimurium TA100 the number of reversions is at least twice as high as the reversion rate of the vehicle control
- in strain Salmonella typhimurium TA98, TA1535, TA1537 and Escherichia coli WP2 uvrA the number of reversions is at least three times higher than the reversion rate of the vehicle control.
According to the guidelines, the biological relevance of the results was the criterion for the interpretation of results, a statistical evaluation of the results was not regarded as necessary.
Criteria for a Negative Response:
A test item is considered non-mutagenic in this bacterial reverse mutation assay if it produces neither a dose-related increase in the number of revertants nor a reproducible biologically relevant positive response at any of the dose groups, with or without metabolic activation. - Statistics:
- The mean values and appropriate standard deviations and mutation rates (mean revertants divided by mean spontaneous revertants) were calculated.
An increase is considered biologically relevant if:
- in strain Salmonella typhimurium TA100 the number of reversions is at least twice as high as the reversion rate of the vehicle control
- in strain Salmonella typhimurium TA98, TA1535, TA1537 and Escherichia coli WP2 uvrA the number of reversions is at least three times higher than the reversion rate of the vehicle control. - Species / strain:
- other: S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Conclusions:
- The reported data of this mutagenicity assay show, that under the experimental conditions reported, the test item did not induce gene mutations by frameshift or base-pair substitution in the genome of the tester strains used. Therefore, 4-ethyl-2-(8-heptadecenyl)-2-oxazoline-4-methanol is considered non-mutagenic in this bacterial reverse mutation assay.
- Executive summary:
Five bacterial strains were used to investigate the mutagenic potential of 4-ethyl-2-(8-heptadecenyl)-2-oxazoline-4-methanol in two independent experiments, in a plate incorporation test (experiment I, Initial Mutation Test) and in a pre-incubation test (experiment II, Confirmatory Mutation Test). The results of the Initial Mutation Test were completed with Complementary Plate Incorporation Test performed in E. coli WP2 uvrA. Each assay was conducted with and without metabolic activation (±S9 Mix). The concentrations, including the controls, were tested in triplicate. In the performed experiments positive and negative (vehicle) controls were run concurrently.
In the performed experiments (in the case of Initial Mutation Test together with its completion) all of the validity criteria, regarding the investigated strains, negative (vehicle) and positive controls, S9 activity and number of investigated analyzable concentration levels were fulfilled.
No substantial increases were observed in revertant colony numbers of any of the five test strains following treatment with 4-ethyl-2-(8-heptadecenyl)-2-oxazoline-4-methanol at any concentration level, either in the presence or absence of metabolic activation (S9 Mix) in the performed experiments.
Sporadic increases in revertant colony numbers compared to the vehicle control values within the actual historical control data ranges were observed in both independently performed main experiments. However, there was no tendency of higher mutation rates with increasing concentrations beyond the generally acknowledged border of biological relevance in the performed experiments.
In the performed experiments inhibitory effect of the test item (absent revertants, decreased number of revertant colony numbers and/or affected background lawn development) was observed in all examined Salmonella typhimurium strains. The 16 μg/plate was found to be the lowest cytotoxic concentration, observed in Confirmatory Mutation Test in the case of Salmonella typhimurium TA1537 strains, in the absence of exogenous metabolic activation (-S9 Mix).
In the Informatory Toxicity Test and Complementary Plate Incorporation Tests) microdrops (precipitate as a colloid-chemical phenomenon) were noticed down to and including the concentration level of 160 μg/plate in absence (-S9 Mix) and at the concentration levels of 5000 and 1600 μg/plate in the presence of exogenous metabolic activation (+S9 Mix). In the Initial Mutation Test microdrops were noticed at the concentration level of 1600 μg/plate in the presence of exogenous metabolic activation (+S9 Mix).
The obtained microdrops (precipitate) did not interfere with the scoring in any case.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
Justification for classification or non-classification
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.